(Reuters) – The U.S. Food and Drug Administration said on Friday it planned to hold a meeting of outside experts on Jan. 26 to discuss whether and how the composition for initial doses of the currently available COVID-19 vaccines should be modified.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Sriraj Kalluvila)
